MannKind Price to Free Cash Flow Ratio 2006-2021 | MNKD

Historical price to free cash flow ratio values for MannKind (MNKD) since 2006. For more information on how our historical price data is adjusted see the Stock Price Adjustment Guide.
MannKind Price to Free Cash Flow Ratio Historical Data
Date Stock Price TTM FCF per Share Price to FCF Ratio
2021-10-15 5.09 0.00
2021-06-30 5.45 $-0.20 0.00
2021-03-31 3.92 $-0.13 0.00
2020-12-31 3.13 $-0.13 0.00
2020-09-30 1.88 $-0.16 0.00
2020-06-30 1.75 $-0.36 0.00
2020-03-31 1.03 $-0.46 0.00
2019-12-31 1.29 $-0.47 0.00
2019-09-30 1.25 $-0.28 0.00
2019-06-30 1.15 $-0.09 0.00
2019-03-31 1.97 $-0.15 0.00
2018-12-31 1.06 $-0.26 0.00
2018-09-30 1.83 $-0.70 0.00
2018-06-30 1.90 $-0.85 0.00
2018-03-31 2.28 $-0.89 0.00
2017-12-31 2.32 $-0.62 0.00
2017-09-30 2.17 $-0.50 0.00
2017-06-30 1.41 $-0.50 0.00
2017-03-31 1.48 $-0.40 0.00
2016-12-31 3.18 $-0.86 0.00
2016-09-30 3.10 $-0.97 0.00
2016-06-30 5.80 $-1.01 0.00
2016-03-31 8.05 $-1.19 0.00
2015-12-31 7.25 $-0.83 0.00
2015-09-30 16.05 $-1.19 0.00
2015-06-30 28.45 $0.37 77.48
2015-03-31 26.00 $0.25 105.65
2014-12-31 26.08 $-0.26 0.00
2014-09-30 29.55 $-0.27 0.00
2014-06-30 54.80 $-2.09 0.00
2014-03-31 20.10 $-2.20 0.00
2013-12-31 26.00 $-2.28 0.00
2013-09-30 28.50 $-2.54 0.00
2013-06-30 32.53 $-2.63 0.00
2013-03-31 16.95 $-2.78 0.00
2012-12-31 11.55 $-3.33 0.00
2012-09-30 14.40 $-3.27 0.00
2012-06-30 11.45 $-4.15 0.00
2012-03-31 12.35 $-5.15 0.00
2011-12-31 12.50 $-5.36 0.00
2011-09-30 18.95 $-6.39 0.00
2011-06-30 19.00 $-6.49 0.00
2011-03-31 18.20 $-6.53 0.00
2010-12-31 40.30 $-6.96 0.00
2010-09-30 33.80 $-7.09 0.00
2010-06-30 31.95 $-7.27 0.00
2010-03-31 32.80 $-8.05 0.00
2009-12-31 43.80 $-9.52 0.00
2009-09-30 49.25 $-11.48 0.00
2009-06-30 41.55 $-13.88 0.00
2009-03-31 17.40 $-15.77 0.00
2008-12-31 17.15 $-17.41 0.00
2008-09-30 19.30 $-17.75 0.00
2008-06-30 15.00 $-19.02 0.00
2008-03-31 29.85 $-20.24 0.00
2007-12-31 39.80 $-20.20 0.00
2007-09-30 48.40 $-21.57 0.00
2007-06-30 61.65 $-21.46 0.00
2007-03-31 71.50 $-21.15 0.00
2006-12-31 82.45 $-20.65 0.00
Sector Industry Market Cap Revenue
Medical Medical - Biomedical and Genetics $1.271B $0.065B
Mannkind Corporation is a biopharmaceutical company focused on the discovery, development and commercialization of therapeutic products for diseases such as diabetes, cancer, inflammatory and autoimmune diseases. The Company's lead product, the Technosphere Insulin System, consists of the Company's dry-powder Technosphere formulation of insulin and the Company's MedTone inhaler through which the powder is inhaled into the deep lung.
Stock Name Country Market Cap PE Ratio
Bristol Myers Squibb (BMY) United States $129.683B 8.63
Bio-Rad Laboratories (BIO.B) United States $21.975B 46.83
QIAGEN (QGEN) Netherlands $11.773B 19.94
Biohaven Pharmaceutical Holding (BHVN) United States $8.738B 0.00
Emergent Biosolutions (EBS) United States $2.722B 6.57
Arcus Biosciences (RCUS) United States $2.455B 0.00
Myovant Sciences (MYOV) United Kingdom $1.915B 0.00
ADC Therapeutics SA (ADCT) Switzerland $1.755B 0.00
Zymeworks (ZYME) Canada $1.208B 0.00
Ambrx Biopharma (AMAM) United States $0.470B 0.00
SQZ Biotechnologies (SQZ) United States $0.342B 0.00
Enzo Biochem (ENZ) United States $0.183B 18.00